Shanghai YingLi Pharmaceutical Co. Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Shanghai China (2011)

Organization Overview

First Clinical Trial
2017
NCT03757000
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shanghai YingLi Pharmaceutical Co. Ltd. | Yingli Pharma US, Inc